HHS issues press release on accelerating biosimilar drug development and lowering drug prices
StreetAccount Summary: EU stocks reaching new 52-week highs/lows (65 total)
Fresenius upgraded to outperform from neutral at Oddo (€49.39, 0.00)
StreetAccount Summary: EU stocks reaching new 52-week highs/lows (93 total)
StreetAccount Summary: EU stocks reaching new 52-week highs/lows (54 total)
Powered by FactSet Research Systems Inc.